Picture BIO Deutschland German Corona Special 2021 Digital 650x80px
Document › Details

Bayer AG. (11/9/20). "Press Release: Bayer Submits Marketing Authorization Applications for Finerenone in the U.S. and the EU for Patients with Chronic Kidney Disease and Type 2 Diabetes". Berlin.

Region Region EU (European Union)
Organisation Organisation Bayer Pharma AG
  Group Bayer (Group)
Products Product finerenone (BAY 94-8862)
  Product 2 phase 3 study
Person Person Möller, Jörg (Bayer 201403–202012 Bayer HealthCare Head of Global Development LEFT 12/20)

Record changed: 2020-12-17


Picture EBD Group Connector Personal Networking in Life Sciences 650x80

More documents for Bayer (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture Berlin Partner Network in German Capital Region 650x80px

» top